New review explores what advances in ATTR-CM therapies mean for patient care
Major advancements have been made in recent years when it comes to treating ATTR-CM, which have positively affected patients’ lives.
All articles by Ashley Welch
-
-
Advice for dealing with a difficult ATTR-CM prognosis
The more you understand, the more empowered you’ll feel.
-
AI has potential to revolutionize how cardiac amyloidosis is diagnosed, researchers say
AI may be a game changer when it comes to recognizing and diagnosing cardiac amyloidosis, according to a new study.
-
Liver enzyme GGT linked to poorer outcomes in ATTR-CM, study finds
New research finds elevated levels of the liver enzyme GGT may help predict severity and outcomes in people with ATTR-CM.
-
New study reveals racial disparities in ATTR-CM outcomes and risk of death
A new study found that patients of Afro-Caribbean descent who have ATTR-CM have worse health outcomes, emphasizing the need for better care.
-
Study reveals high burden on patients and families affected by ATTR-CM
New research finds worsening symptoms significantly affect quality of life in people with ATTR-CM and cause caregivers strain.
-
New tool to identify cardiac amyloidosis risk in African American veterans
Researchers developed a new dashboard to identify African American veterans at risk of cardiac amyloidosis, including hereditary ATTR-CM.
-
Vutrisiran slows disease and reduces hospitalizations in ATTR-CM, study finds
A new study building on the results of the HELIOS-B trial found further evidence of vutrisiran’s beneficial effects for people with ATTR-CM.
-
Wild-type ATTR-CM carries higher risks for Black individuals, study finds
Black people with wild-type ATTR-CM had worse outcomes, even after accounting for factors like age, kidney disease and heart function.
-
Catheter ablation improves outcomes for early-stage ATTR-CM, study finds
A new study found that a common treatment for atrial fibrillation may improve outcomes for patients with early-stage ATTR-CM.
